Galapagos receives €4 million in milestones from Servier

10-Feb-2011 - Belgium

Galapagos NV  announced that it reached milestones in its osteoarthritis alliance with Servier, resulting in payments in 2010 revenues totaling €4 million from Servier.

In July 2010, Servier and Galapagos announced their alliance to develop new medicines for the treatment of osteoarthritis.  Galapagos is responsible for the discovery and development of new candidate drugs and Servier has an exclusive option to license these after the completion of Phase I clinical trials by Galapagos.  To date, Galapagos has received a total of €11 million in payments from Servier under the alliance.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances